Synchron CEO on first FDA approved brain chip implant for paralysis
Synchron CEO Dr. Thomas Oxley on receiving FDA approval for clinical trials in the U.S. and discusses the benefits of his company's brain-computer interface device.
https://ift.tt/3C1FmXI
